Imara Overview

  • Founded
  • 2016
Founded
  • Status
  • Public
  • Employees
  • 20
Employees
  • Stock Symbol
  • IMRA
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $9.97
  • (As of Friday Closing)

Imara General Information

Description

Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 116 Huntington Avenue
  • 6th Floor
  • Boston, MA 02116
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Imara Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.97 $12.31 $8.50 - $62.71 $174M 17.4M 135K -$3.73

Imara Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 246,110
Revenue 0 0 0
EBITDA (37,525) (24,008) (11,337)
Net Income (37,092) (23,463) (11,337)
Total Assets 100,175 33,298 7,705
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Imara Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Imara‘s full profile, request access.

Request a free trial

Imara Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Imara‘s full profile, request access.

Request a free trial

Imara Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to
Biotechnology
Boston, MA
20 As of 2020
00000
0000 0000-00-00
00000000 00000

00000000

sum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
0000 000000000
Novato, CA
000 As of 0000
00000
000000000 00000

0000000

iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ven
0000000000000
New York, NY
00 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Imara Competitors (48)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ultragenyx Pharmaceutical Formerly VC-backed Novato, CA 000 00000 000000000 00000
0000000 0000000000 Formerly VC-backed New York, NY 00 00000 000000&0 00000
00000 000000000 Formerly VC-backed Boulder, CO 000 00000 000000&0 00000
000000 000000000 Formerly PE-Backed Germantown, MD 0 000.00 000000&0 000.00
00000 Formerly VC-backed Cambridge, MA 000 00000 000000&0
You’re viewing 5 of 48 competitors. Get the full list »

Imara Executive Team (8)

Name Title Board Seat Contact Info
Rahul Ballal Ph.D Chief Executive Officer & Board Member
Michael Gray Chief Financial Officer & Chief Operating Officer
Michael Gray Chief Financial Officer, Finance & Chief Operating Officer, Operations
Kenneth Attie MD Senior Vice President & Chief Medical Officer
You’re viewing 4 of 8 executive team members. Get the full list »

Imara Board Members (20)

Name Representing Role Since
Barbara Dalton Ph.D Self Board Member 000 0000
Carl Goldfischer MD Bay City Capital Board Member 000 0000
David Bonita MD Self Board Member 000 0000
David Mott Self Chairman & Board Member 000 0000
Edward Conner MD Imara Board Member 000 0000
You’re viewing 5 of 20 board members. Get the full list »

Imara Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Imara Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Imara‘s full profile, request access.

Request a free trial

Imara Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (00000000 16-Apr-2016 000000000 00000 00 Buildings and Property
To view Imara’s complete investments history, request access »